服裝紡織板塊拉昇 印度疫情失控 紡織訂單迴流預期升温
格隆匯4月27日丨服裝紡織板塊午前異動拉昇,美邦服飾、日播時尚、奧康國際等多股漲停,朗姿股份漲超8%。印度疫情全面失控,4月以來,印度日增新冠確診病例數連創新高。印專家根據疫情模型預測,印度新冠疫情將在5月達到峯值,未來10天平均日增病例將達到44萬例。業內認為,印度是全球最大的紡織大國,其中紗線及中低端家紡等領域在全球佔有重要地位。受疫情不斷失控影響,印度紡織業停工停產將不可避免。根據去年海外訂單迴流情況,家紡相關產品及下游紗線等品種需求望明顯增長。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.